Raymond James analyst Jayson Bedford lowered the price target on ICU Medical (NASDAQ: ICUI) to $300.00 (from $315.00) while maintaining a Strong Buy rating.

Bedford said while Q4 was nicely above the mix was different than their thinking. The firm trimmed revenue estimates to hopefully reflect a bit more conservatism (and a volatile IV Solutions environment) but made no changes to EBITDA expectations.